Xalatan drops eye

Šalis: Armėnija

kalba: anglų

Šaltinis: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Veiklioji medžiaga:

latanoprost

Prieinama:

Pfizer Manufacturing Belgium N.V.

ATC kodas:

S01EE01

INN (Tarptautinis Pavadinimas):

latanoprost

Dozė:

50mcg/ml

Vaisto forma:

drops eye

Vienetai pakuotėje:

2,5ml plastic container

Recepto tipas:

Prescription

Autorizacija statusas:

Registered

Leidimo data:

2018-10-03

Prekės savybės

...........'.:::.:...lll.:f
I:
NAME
OF
THE MEDICINAL
PRODUCT
Xa
atan
0.005%
w/v
ey'e
d1'ops
solution"
2,...,..$uxritxtwn
**n,..OuffiAnrVe
CbMposttibt,l
I00
ml eyerlrops solution
contains
0.005 g
latanclprost.
One
d
rop
:bontainS
approxi
rnately
1
.
5
m
icrogranr
s
latanol:rost.
lixciBienf:
Benzalkoniunr
chlor,ide
0.02%rv/v
is
includecl
as
a
prescrvativc.
For
a
firll
list
of excipienls.
se€r
section
6.1.
s\
t',,',,,,,,,,
*uunraef,!..ff0t
ff
'
Eye
drops,
solution.
The
s$tution,is,:a
'e
ar
co{ou-ri'l
s
iiwid.
.l....*****eIJLA.R,s.:...]..:..::.:':..-
ott
,.,,,'fe,9
urie
indicatioo*
i
Rerluction
of
elevatecl
intraocular
pressure
irr
patients
rvith
open
angle
glaucorna
and
ocular
hvpeftension:
'''
Reduction ot-elevap.$rintracrcular
pressure
in
paediatric patients
rryitlr
elevate"cl
intraocular
pressure
and
pacdiatric glaucoma,
''
*"l
fas1
a**
ni*UoC
*f*crrr
tion
,
'
Reco
n
mt
e
ne{e
tl,
c}o
s
age
"fo
t'
a
d
ylts
(i
nclud
i n
g
t
he
e
I
d
g
r
I
1y
'
neeomn
ed,therapy
is
one
eye
drop
!n
theaffietd,e
e(slo'ne:e
dhity,
{l$timal
effear,is
,!9feu,,ittXakran,
is
*dnih
The
dosage
uf
Xuiuturi
should not
exceed
once
daily
since
it
has
lreen
shoil'n
that
rnore
ficcluent
adlinisttxrun
decreasel
the
intraocular
pressurE
lowering
eflect.
It.otr+.d*sekmissed,treatnlcnt.1l.|
eotfiinue
with
the next
dose
as
normal
,:
.
,
*$*itii'iar*ll
e1,'e iops;iib:.redu0s
fi
ilt'le,sy$tqrl.ic
abrs-orptiorr,
it:'ls recommerrclccl
that
the
leehrysXsactje,eon"pr;
-ed
at'the
rn
ial'canthus
(punctal
occlusion)
ior
one
rninutc.
'I'his
shoirl.dr,be
pe.r{'.brmed
imrrrediate,ly:
llowiiigthe
irrstillation
of
eaell
drop.
Appltcant
/
nare
/)p/.//.
Cont
leniesshcritd
bC
rgmo,vei{,'beJiire
insliilation
of
fhe.
eye
drops and
ma-v
be r,einserted
after
I5
minutes.
:
lf
more than
one
topicaf
.ophtliairr*edru$
is.being
r$td:
thb
dr
shorild
be,adr,nlnistered
hl
least
five
rninutes apart.
P
se
di ut
t:
ic
pop
t
lut
i
ott
:
Xalrrtan,,eye
d16ps
may
be'
used,in.,paediatr,ic
patients
at
the
sanre
posol*g5i
as
in adults.
No
data
are
available
for
pretenl
in:fbnts
(iess
thf